Global Herpes Treatment Market Research Report 2023

Report ID: 1989000 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
1 Herpes Treatment Market Overview
    1.1 Product Overview and Scope of Herpes Treatment
    1.2 Herpes Treatment Segment by Type
        1.2.1 Global Herpes Treatment Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Acyclovir
        1.2.3 Valacyclovir
        1.2.4 Famciclovir
    1.3 Herpes Treatment Segment by Application
        1.3.1 Global Herpes Treatment Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
        1.3.5 Drug Stores
    1.4 Global Herpes Treatment Market Size Estimates and Forecasts
        1.4.1 Global Herpes Treatment Revenue 2017-2028
        1.4.2 Global Herpes Treatment Sales 2017-2028
        1.4.3 Herpes Treatment Market Size by Region: 2017 Versus 2021 Versus 2028
2 Herpes Treatment Market Competition by Manufacturers
    2.1 Global Herpes Treatment Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Herpes Treatment Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Herpes Treatment Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Herpes Treatment Manufacturing Sites, Area Served, Product Type
    2.5 Herpes Treatment Market Competitive Situation and Trends
        2.5.1 Herpes Treatment Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Herpes Treatment Players Market Share by Revenue
        2.5.3 Global Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Herpes Treatment Retrospective Market Scenario by Region
    3.1 Global Herpes Treatment Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Herpes Treatment Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Herpes Treatment Market Facts & Figures by Country
        3.3.1 North America Herpes Treatment Sales by Country
        3.3.2 North America Herpes Treatment Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Herpes Treatment Market Facts & Figures by Country
        3.4.1 Europe Herpes Treatment Sales by Country
        3.4.2 Europe Herpes Treatment Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Herpes Treatment Market Facts & Figures by Region
        3.5.1 Asia Pacific Herpes Treatment Sales by Region
        3.5.2 Asia Pacific Herpes Treatment Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Herpes Treatment Market Facts & Figures by Country
        3.6.1 Latin America Herpes Treatment Sales by Country
        3.6.2 Latin America Herpes Treatment Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Herpes Treatment Market Facts & Figures by Country
        3.7.1 Middle East and Africa Herpes Treatment Sales by Country
        3.7.2 Middle East and Africa Herpes Treatment Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Herpes Treatment Historic Market Analysis by Type
    4.1 Global Herpes Treatment Sales Market Share by Type (2017-2022)
    4.2 Global Herpes Treatment Revenue Market Share by Type (2017-2022)
    4.3 Global Herpes Treatment Price by Type (2017-2022)
5 Global Herpes Treatment Historic Market Analysis by Application
    5.1 Global Herpes Treatment Sales Market Share by Application (2017-2022)
    5.2 Global Herpes Treatment Revenue Market Share by Application (2017-2022)
    5.3 Global Herpes Treatment Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Gilead
        6.1.1 Gilead Corporation Information
        6.1.2 Gilead Description and Business Overview
        6.1.3 Gilead Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Gilead Herpes Treatment Product Portfolio
        6.1.5 Gilead Recent Developments/Updates
    6.2 GlaxoSmithKline
        6.2.1 GlaxoSmithKline Corporation Information
        6.2.2 GlaxoSmithKline Description and Business Overview
        6.2.3 GlaxoSmithKline Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 GlaxoSmithKline Herpes Treatment Product Portfolio
        6.2.5 GlaxoSmithKline Recent Developments/Updates
    6.3 Merck
        6.3.1 Merck Corporation Information
        6.3.2 Merck Description and Business Overview
        6.3.3 Merck Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Merck Herpes Treatment Product Portfolio
        6.3.5 Merck Recent Developments/Updates
    6.4 Novartis
        6.4.1 Novartis Corporation Information
        6.4.2 Novartis Description and Business Overview
        6.4.3 Novartis Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Novartis Herpes Treatment Product Portfolio
        6.4.5 Novartis Recent Developments/Updates
    6.5 Abbott
        6.5.1 Abbott Corporation Information
        6.5.2 Abbott Description and Business Overview
        6.5.3 Abbott Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Abbott Herpes Treatment Product Portfolio
        6.5.5 Abbott Recent Developments/Updates
    6.6 Mylan
        6.6.1 Mylan Corporation Information
        6.6.2 Mylan Description and Business Overview
        6.6.3 Mylan Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Mylan Herpes Treatment Product Portfolio
        6.6.5 Mylan Recent Developments/Updates
    6.7 Teva Pharmaceutical Industries
        6.6.1 Teva Pharmaceutical Industries Corporation Information
        6.6.2 Teva Pharmaceutical Industries Description and Business Overview
        6.6.3 Teva Pharmaceutical Industries Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Teva Pharmaceutical Industries Herpes Treatment Product Portfolio
        6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates
    6.8 Vical
        6.8.1 Vical Corporation Information
        6.8.2 Vical Description and Business Overview
        6.8.3 Vical Herpes Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Vical Herpes Treatment Product Portfolio
        6.8.5 Vical Recent Developments/Updates
7 Herpes Treatment Manufacturing Cost Analysis
    7.1 Herpes Treatment Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Herpes Treatment
    7.4 Herpes Treatment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Herpes Treatment Distributors List
    8.3 Herpes Treatment Customers
9 Herpes Treatment Market Dynamics
    9.1 Herpes Treatment Industry Trends
    9.2 Herpes Treatment Market Drivers
    9.3 Herpes Treatment Market Challenges
    9.4 Herpes Treatment Market Restraints
10 Global Market Forecast
    10.1 Herpes Treatment Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Herpes Treatment by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Herpes Treatment by Type (2023-2028)
    10.2 Herpes Treatment Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Herpes Treatment by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Herpes Treatment by Application (2023-2028)
    10.3 Herpes Treatment Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Herpes Treatment by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Herpes Treatment by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Herpes Treatment Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Herpes Treatment Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Herpes Treatment Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Herpes Treatment Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Herpes Treatment Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Herpes Treatment Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Herpes Treatment Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Herpes Treatment Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Herpes Treatment Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Herpes Treatment Manufacturing Sites and Area Served
    Table 11. Manufacturers Herpes Treatment Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Herpes Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Treatment as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Herpes Treatment Sales by Region (2017-2022) & (K Units)
    Table 16. Global Herpes Treatment Sales Market Share by Region (2017-2022)
    Table 17. Global Herpes Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Herpes Treatment Revenue Market Share by Region (2017-2022)
    Table 19. North America Herpes Treatment Sales by Country (2017-2022) & (K Units)
    Table 20. North America Herpes Treatment Sales Market Share by Country (2017-2022)
    Table 21. North America Herpes Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Herpes Treatment Revenue Market Share by Country (2017-2022)
    Table 23. Europe Herpes Treatment Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Herpes Treatment Sales Market Share by Country (2017-2022)
    Table 25. Europe Herpes Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Herpes Treatment Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Herpes Treatment Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Herpes Treatment Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Herpes Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Herpes Treatment Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Herpes Treatment Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Herpes Treatment Sales Market Share by Country (2017-2022)
    Table 33. Latin America Herpes Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Herpes Treatment Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Herpes Treatment Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Herpes Treatment Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Herpes Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Herpes Treatment Revenue Market Share by Country (2017-2022)
    Table 39. Global Herpes Treatment Sales by Type (2017-2022) & (K Units)
    Table 40. Global Herpes Treatment Sales Market Share by Type (2017-2022)
    Table 41. Global Herpes Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Herpes Treatment Revenue Share by Type (2017-2022)
    Table 43. Global Herpes Treatment Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Herpes Treatment Sales (K Units) by Application (2017-2022)
    Table 45. Global Herpes Treatment Sales Market Share by Application (2017-2022)
    Table 46. Global Herpes Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Herpes Treatment Revenue Share by Application (2017-2022)
    Table 48. Global Herpes Treatment Price by Application (2017-2022) & (USD/Unit)
    Table 49. Gilead Corporation Information
    Table 50. Gilead Description and Business Overview
    Table 51. Gilead Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Gilead Herpes Treatment Product
    Table 53. Gilead Recent Developments/Updates
    Table 54. GlaxoSmithKline Corporation Information
    Table 55. GlaxoSmithKline Description and Business Overview
    Table 56. GlaxoSmithKline Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. GlaxoSmithKline Herpes Treatment Product
    Table 58. GlaxoSmithKline Recent Developments/Updates
    Table 59. Merck Corporation Information
    Table 60. Merck Description and Business Overview
    Table 61. Merck Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Merck Herpes Treatment Product
    Table 63. Merck Recent Developments/Updates
    Table 64. Novartis Corporation Information
    Table 65. Novartis Description and Business Overview
    Table 66. Novartis Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Novartis Herpes Treatment Product
    Table 68. Novartis Recent Developments/Updates
    Table 69. Abbott Corporation Information
    Table 70. Abbott Description and Business Overview
    Table 71. Abbott Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Abbott Herpes Treatment Product
    Table 73. Abbott Recent Developments/Updates
    Table 74. Mylan Corporation Information
    Table 75. Mylan Description and Business Overview
    Table 76. Mylan Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Mylan Herpes Treatment Product
    Table 78. Mylan Recent Developments/Updates
    Table 79. Teva Pharmaceutical Industries Corporation Information
    Table 80. Teva Pharmaceutical Industries Description and Business Overview
    Table 81. Teva Pharmaceutical Industries Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Teva Pharmaceutical Industries Herpes Treatment Product
    Table 83. Teva Pharmaceutical Industries Recent Developments/Updates
    Table 84. Vical Corporation Information
    Table 85. Vical Description and Business Overview
    Table 86. Vical Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Vical Herpes Treatment Product
    Table 88. Vical Recent Developments/Updates
    Table 89. Production Base and Market Concentration Rate of Raw Material
    Table 90. Key Suppliers of Raw Materials
    Table 91. Herpes Treatment Distributors List
    Table 92. Herpes Treatment Customers List
    Table 93. Herpes Treatment Market Trends
    Table 94. Herpes Treatment Market Drivers
    Table 95. Herpes Treatment Market Challenges
    Table 96. Herpes Treatment Market Restraints
    Table 97. Global Herpes Treatment Sales Forecast by Type (2023-2028) & (K Units)
    Table 98. Global Herpes Treatment Sales Market Share Forecast by Type (2023-2028)
    Table 99. Global Herpes Treatment Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 100. Global Herpes Treatment Revenue Market Share Forecast by Type (2023-2028)
    Table 101. Global Herpes Treatment Sales Forecast by Application (2023-2028) & (K Units)
    Table 102. Global Herpes Treatment Sales Market Share Forecast by Application (2023-2028)
    Table 103. Global Herpes Treatment Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 104. Global Herpes Treatment Revenue Market Share Forecast by Application (2023-2028)
    Table 105. Global Herpes Treatment Sales Forecast by Region (2023-2028) & (K Units)
    Table 106. Global Herpes Treatment Sales Market Share Forecast by Region (2023-2028)
    Table 107. Global Herpes Treatment Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 108. Global Herpes Treatment Revenue Market Share Forecast by Region (2023-2028)
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Herpes Treatment
    Figure 2. Global Herpes Treatment Market Share by Type in 2021 & 2028
    Figure 3. Acyclovir Product Picture
    Figure 4. Valacyclovir Product Picture
    Figure 5. Famciclovir Product Picture
    Figure 6. Global Herpes Treatment Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacies
    Figure 8. Retail Pharmacies
    Figure 9. Online Pharmacies
    Figure 10. Drug Stores
    Figure 11. Global Herpes Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Herpes Treatment Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Herpes Treatment Sales (2017-2028) & (K Units)
    Figure 14. Herpes Treatment Sales Share by Manufacturers in 2021
    Figure 15. Global Herpes Treatment Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Herpes Treatment Players: Market Share by Revenue in 2021
    Figure 17. Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Herpes Treatment Sales Market Share by Region (2017-2022)
    Figure 19. Global Herpes Treatment Sales Market Share by Region in 2021
    Figure 20. Global Herpes Treatment Revenue Market Share by Region (2017-2022)
    Figure 21. Global Herpes Treatment Revenue Market Share by Region in 2021
    Figure 22. U.S. Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Taiwan Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Philippines Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Vietnam Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Mexico Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Brazil Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Argentina Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Turkey Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Saudi Arabia Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. U.A.E Herpes Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Sales Market Share of Herpes Treatment by Type (2017-2022)
    Figure 47. Manufacturing Cost Structure of Herpes Treatment
    Figure 48. Manufacturing Process Analysis of Herpes Treatment
    Figure 49. Herpes Treatment Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead
GlaxoSmithKline
Merck
Novartis
Abbott
Mylan
Teva Pharmaceutical Industries
Vical
Frequently Asked Questions
Herpes Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Herpes Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Herpes Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports